spacer
home > epc > spring 2002 > what you should expect from a user-friendly edc solution
PUBLICATIONS
European Pharmaceutical Contractor

What You Should Expect from a User-Friendly EDC Solution

'User-friendly' is one of the most commonly misunderstood phrases in the computer lexicon. For years, every software package claimed to be 'user-friendly', diluting what the term actually means. Many purchasing agents began to ignore the claim because it was so difficult to quantify. Consequently, the term all but disappeared.

However, in the world of clinical trial software, it is dangerous to ignore the term 'user-friendly' in evaluations - particularly when investigator sites place such high importance on the concept. Being 'user-friendly' is an important criteria for software selection, but the trick is defining user-friendliness in a way that meets the needs of sites.

A critical point about the EDC selection process is that, generally, the decision-makers are the sponsor companies, and often the data management team for these companies plays an important role in the choice of EDC vendor. Although it is important that EDC software meet the data management requirements, it is absolutely critical that the initial users of the software (the personnel at the investigator site and the data monitors), readily accept the software. Without the site and monitor 'buy-in', data won't be entered into the site in a timely fashion and the software won't be used effectively. Without clean data available to data management, the usefulness of EDC is minimised.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Thomas Haskell, Director of Product Management at CB Technologies, Inc

Tom Haskell is Director of Product Management at CB Technologies, Inc. In this position, he is responsible for the strategic direction of the company's suite of clinical trial software products. A graduate of Harvard University, he has over 20 years of experience in software product strategy and full software life cycle development in many different industries.

Tom began his tenure at CB as a Strategic Consultant for many of the top pharmaceutical companies, including Pfizer and Aventis. Prior to joining CB, he served as Vice President and General Manager for MapQuest.com, a supplier of travel information on the Internet.

spacer
Thomas Haskell
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st – 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement